The Brief Screener for Tobacco, Alcohol, and other Drugs (BSTAD) tool consists of frequency of use questions to identify risky substance use by adolescent patients.
The Screening to Brief Intervention (S2BI) screening tool consists of frequency of use questions to categorize substance use by adolescent patients into different risk categories.
The BSTAD and S2BI APIs do not have any parameters and will return all questions or summaries for a given screening tool. As such, simply using the API endpoints is enough. To access the APIs you must have an API key. The API key must be passed as a header value assigned to the x-api-key property.
You can register for an API key by completing the API Gateway Registration form.
For additional information, terms of use, and FAQs, please see our NIDA Screening Tool APIs: Overview for Developers page.
BSTAD and S2BI share the same question API. However, each endpoint presents different data. The endpoints are as follows:
Below is an example of the response from the endpoints.
{
questions: [
{
id: "20520",
title: "In the PAST YEAR, on how many days did you smoke cigarettes or use other tobacco products?",
description: "",
field_type: "slider",
answers: "365",
starting_question: "1",
drugs: "Tobacco",
dependencies: "",
hasSubs: "No",
risk_value: null
}
]
}
The Summaries API is the same for BSTAD and S2BI and they present the same data. To access the API you must have an API key. You can register for an API key here: (coming soon). The endpoints are as follows:
Below is an example of the response from the endpoints.
{
{
summary: [
{
title: "Tobacco Risk Level: Lower Risk",
riskLevel: "Low",
description: "<h4>Implications of the Score</h4> <p>Adolescents reporting tobacco use in the past twelve months with this frequency have not yet established a regular pattern of use, and are at lower risk for currently meeting criteria for a nicotine use disorder. However, use may become more frequent and, given the very high addiction potential of nicotine, a disorder may develop with continued use. Patients may also be underreporting their use of other tobacco or nicotine-related products, such as e-cigarettes, hookah, or smokeless tobacco.</p> <h4>Suggested Clinician Action</h4> <p>The recommended intervention for all teens with lower risk tobacco use is to deliver a cessation message encouraging them not to use again.</p> <h4>Advise to Quit</h4> <ul> <li>“I would recommend for the sake of your health that you do not use tobacco or other nicotine products like e-cigarettes.”</li> <li>“I know that being healthy is important to you. One of the best things you can do to keep your body fit is to avoid using tobacco or other nicotine products like e-cigarettes.”</li> </ul> <h4>References and Additional Resources</h4> <ul> <li>National Cancer Institute. Smokefree teen. <a href="http://teen.smokefree.gov/">http://teen.smokefree.gov</a></li> <li>American Academy of Pediatrics Julius B. Richmond Center of Excellence. Counseling about smoking cessation. <a href="http://www2.aap.org/richmondcenter/counselingaboutsmokingcessation.html">http://www2.aap.org/richmondcenter/counselingaboutsmokingcessation.html</a></li> <li>Massachusetts Department of Health. QuitWorks. <a href="http://quitworks.makesmokinghistory.org">http://quitworks.makesmokinghistory.org</a></li> <li>Fiore, M. C., Jaén, C. R., Baker, T. B., et al. (2008). <a href="https://www.ncbi.nlm.nih.gov/books/NBK63952/"><em>Treating tobacco use and dependence: 2008 update.</em></a> Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. <a href="https://www.ncbi.nlm.nih.gov/books/NBK63952/">https://www.ncbi.nlm.nih.gov/books/NBK63952/</a></li> <li>Committee on Environmental Health, Committee on Substance Abuse, Committee on Adolescence, and Committee on Native American Child Health. (2009). Policy statement: Tobacco use: A pediatric disease. <em>Pediatrics. 124</em>(5), 1474–1487. Reaffirmed May 2013. <a href="http://pediatrics.aappublications.org/content/124/5/1474">http://pediatrics.aappublications.org/content/124/5/1474</a></li> <li>Karpinski, J. P., Timpe, E. M., & Lubsch, L. (2010). Smoking Cessation Treatment for Adolescents. <em>The Journal of Pediatric Pharmacology and Therapeutics: JPPT, 15</em>(4), 249–263. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042263/">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042263/</a></li> </ul>",
drug: "Tobacco",
toolType: null
}
}
First please consider going through the tools that exist at https://www.drugabuse.gov/ast/s2bi and https://www.drugabuse.gov/ast/bstad
Going through both of these tools will give a general idea of how the two api parts should work together. In short:
In general, your application will need to make a call to get the all the questions and handle the logic to proceed through the questions. The logic for the questions is handled via the dependency field on each question.
Each question has a dependency. This is how the application knows what question to display. The dependencies are based on the id of the parent question or questions and how they were answered. So if a question has a value of 20520|!0, that means that if the question with the id of 20520 had an answer that was not 0, this question should be displayed. Multiple dependencies are separated by commas.
Risk Levels are used to display the correct summary result information. In S2BI and BSTAD, the risk level is assessed based on what questions are asked and how they are answered. There are three risk levels minimal, low, and high and the risk levels are specific to each drug.